Edit
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global 3D Printed Drugs Market to reach USD 195.10 million by 2028.

Global 3D Printed Drugs Market Size study, by Technology (Inkjet Printing, Zipdose Technology, Stereolithography, Fused Deposition Modeling), By Application (Orthopedic, Neurology, Dental, Others), By End-use (Hospitals & clinics, Research Laboratories, Others) and Regional Forecasts 2022-2028

Product Code: HLSDT-55316383
Publish Date: 15-09-2022
Page: 200

Global 3D Printed Drugs Market is valued at approximately USD 72.02 million in 2021 and is anticipated to grow with a healthy growth rate of more than 15.30% over the forecast period 2022-2028. 3D printed drugs are prescriptions created with the 3D printing process to provide individuals with safe and effective tailored medications. These drugs don’t need to be swallowed whole because of the unitary porous architecture that makes it simple for them to scatter in the mouth. It makes it simple for producers to alter the size, shape, appearance, and rate of distribution of a variety of medications. The market is booming as a result of rising demand for personalized drugs and rapidly expanding R&D activities supporting 3D printing. By producing personalized medical therapies, this technology creates promising opportunities for improving patient care. To make pharmaceuticals safer and more effective, pharmaceutical research companies have also been looking into the development of more specialised remedies since the establishment of the United States Personalized Medicine Initiative in 2015. As a result, demand for 3D-printed drugs is expected to increase in the coming years.Increased investments by operating players in the production of advanced and effective 3D printed pharmaceuticals, as well as breakthroughs in 3D printing technology, are expected to drive market growth over the forecast period. CurfiyLabs and Natural Machines, for example, collaborated in March 2022 on the production of these medicines based on the needs of individual patients. This is expected to allow pharmacies and hospitals to receive medications more quickly. However, the adverse effects of these drugs, the development of illicit drugs using 3D printing and the absence of government restrictions for 3D printed goods are two factors that are limiting market expansion. On the other hand, growing public knowledge of the advantages of these medications, such as their rapid solubility, along with breakthroughs in healthcare systems and technology in emerging nations, are anticipated to create a wide range of potential for market expansion.

The key regions considered for the global 3D Printed Drugs market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia Pacific has the largest market share in the 3D printed drugs market and is expected to grow at a healthy CAGR during the forecast period. Rapid development of healthcare infrastructure and increased investment in healthcare research and development are expected to drive the growth of the Asia Pacific 3D printed drugs market. The Europe region is also expected to grow satisfactorily during the forecast period, owing to rising health consciousness among Europeans.

Major market players included in this report are:
Extend Biosciences
BioDuro
Affinity Therapeutics
Osmotica Pharmaceuticals
Aprecia Pharmaceuticals LLC
GlaxoSmithKline Plc
FabRx Ltd
Hewlett Packard Caribe
Merck
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
ByTechnology:
Inkjet Printing
Fused Deposition Modeling
Stereolithography
ZipDose Technology

By Application:
Orthopedic
Neurology
Dental
Others
By End-use:
Hospitals & clinics
Research Laboratories
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global 3D Printed Drugs Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. 3D Printed Drugs Market, by Region, 2020-2028 (USD Million)
1.2.2. 3D Printed Drugs Market, by Technology,2020-2028 (USD Million)
1.2.3. 3D Printed Drugs Market, by Application,2020-2028 (USD Million)
1.2.4. 3D Printed Drugs Market, by End-use,2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global 3D Printed Drugs Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global 3D Printed Drugs Market Dynamics
3.1. 3D Printed Drugs Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Rising Usage Of 3D Printing in The Medical Industries
3.1.1.2. Increasing Adoption of Personalized Drugs
3.1.2. Market Challenges
3.1.2.1. Lack Of Government Regulations for 3D Printed Products
3.1.3. Market Opportunities
3.1.3.1. High Demand for Instantaneous Soluble Tablets
Chapter 4. Global 3D Printed Drugs Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global 3D Printed Drugs Market, by Technology
6.1. Market Snapshot
6.2. Global 3D Printed Drugs Market by Technology, Performance – Potential Analysis
6.3. Global 3D Printed Drugs Market Estimates & Forecasts by Technology,2018-2028 (USD Million)
6.4. 3D Printed Drugs Market, Sub Segment Analysis
6.4.1. Inkjet Printing
6.4.2. Fused Deposition Modeling
6.4.3. Stereolithography
6.4.4. ZipDose Technology
Chapter 7. Global 3D Printed Drugs Market, by Application
7.1. Market Snapshot
7.2. Global 3D Printed Drugs Market by Application, Performance – Potential Analysis
7.3. Global 3D Printed Drugs Market Estimates & Forecasts by Application,2018-2028 (USD Million)
7.4. 3D Printed Drugs Market, Sub Segment Analysis
7.4.1. Orthopedic
7.4.2. Neurology
7.4.3. Dental
7.4.4. Others
Chapter 8. Global 3D Printed Drugs Market, by End-use
8.1. Market Snapshot
8.2. Global 3D Printed Drugs Market by End-use, Performance – Potential Analysis
8.3. Global 3D Printed Drugs Market Estimates & Forecasts by End-use,2018-2028 (USD Million)
8.4. 3D Printed Drugs Market, Sub Segment Analysis
8.4.1. Hospitals & clinics
8.4.2. Research Laboratories
8.4.3. Others
Chapter 9. Global 3D Printed Drugs Market, Regional Analysis
9.1. Global 3D Printed Drugs Market, Regional Market Snapshot
9.2. North America 3D Printed Drugs Market
9.2.1. U.S. 3D Printed Drugs Market
9.2.1.1. Technology breakdown estimates & forecasts, 2018-2028
9.2.1.2. Application breakdown estimates & forecasts, 2018-2028
9.2.1.3. End-use breakdown estimates & forecasts, 2018-2028
9.2.2. Canada3D Printed Drugs Market
9.3. Europe 3D Printed Drugs Market Snapshot
9.3.1. U.K. 3D Printed Drugs Market
9.3.2. Germany 3D Printed Drugs Market
9.3.3. France 3D Printed Drugs Market
9.3.4. Spain 3D Printed Drugs Market
9.3.5. Italy 3D Printed Drugs Market
9.3.6. Rest of Europe3D Printed Drugs Market
9.4. Asia-Pacific 3D Printed Drugs Market Snapshot
9.4.1. China 3D Printed Drugs Market
9.4.2. India 3D Printed Drugs Market
9.4.3. Japan 3D Printed Drugs Market
9.4.4. Australia 3D Printed Drugs Market
9.4.5. South Korea 3D Printed Drugs Market
9.4.6. Rest of Asia Pacific 3D Printed Drugs Market
9.5. Latin America 3D Printed Drugs Market Snapshot
9.5.1. Brazil 3D Printed Drugs Market
9.5.2. Mexico 3D Printed Drugs Market
9.6. Rest of The World 3D Printed Drugs Market

Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Extend Biosciences

10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Application Summary
10.2.1.5. Recent Developments
10.2.2. Bioduro
10.2.3. Affinity Therapeutics
10.2.4. Osmotica Pharmaceuticals
10.2.5. Aprecia Pharmaceuticals LLC
10.2.6. GlaxoSmithKline Plc
10.2.7. FabRx Ltd
10.2.8. Hewlett Packard Caribe
10.2.9. Merck
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption

The study of the market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. Our analysts contact company executives, managers, key opinion leaders, and industry experts. This enables our analyst to derive the closest possible figures without any major deviations in the actual number.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.
Enquiry Now